Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of theabrownin in the preparation of anti-melanoma drugs

An anti-melanin, theabrownin technology, applied in anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve problems such as unclear effects and no research reports

Active Publication Date: 2022-03-08
杭州茗褐生物科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its effect on skin cancers such as melanoma is unclear, and there are no relevant research reports

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of theabrownin in the preparation of anti-melanoma drugs
  • Application of theabrownin in the preparation of anti-melanoma drugs
  • Application of theabrownin in the preparation of anti-melanoma drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1: Anti-proliferation effect of theabrownin (TB) on A375 cells

[0026] The effect of TB on the proliferation ability of A375 cells was evaluated by MTT assay and morphological observation. A375 cells in the logarithmic growth phase were taken, and 6×10 3Inoculate in a 96-well plate at a density of one per well, with 200 μl of medium per well. After the cells were completely attached to the wall, different concentrations of TB were given for 24, 48 and 72 hours. TB administration concentrations were 0, 40, 80, 120, 160, 200, 240 and 280 μg / ml. After the drug intervention was completed, the morphology of living cells was observed under a microscope. Add 20 μl of MTT reagent (5.0 mg / ml) to each well and incubate at 37°C for 4 hours in the dark. After incubation, 150 μl DMSO was added to each well, and shaken at room temperature for 10 minutes in the dark. Using a microplate reader, detect the optical density value (OD value) at a wavelength of 490 nm, and cal...

Embodiment 2

[0029] Example 2: Pro-apoptotic effect of theabrownin (TB) on A375 cells

[0030] DAPI staining and flow cytometry were used to evaluate the effects of low, medium and high concentrations of TB on the pro-apoptotic effect of A375 cells after 24 hours. A375 cells were seeded in 24-well plates covered with cell slides, and treated with low, medium and high concentrations of TB. After 24 hours of intervention, the cells were washed 3 times with PBS and fixed with 4% paraformaldehyde for 1 hour. After the cell slides were washed with PBS, they were permeabilized with 0.1% sodium citrate solution containing 0.1% Triton X-100 at 4°C for 2 min. Wash twice with PBS, and seal the slides with DAPI reagent at room temperature in the dark. After the slides were dried, they were placed under a fluorescence microscope to observe the cells and collect image data.

[0031] The result is as figure 2 As shown in A, after DAPI staining, the normal control group had intact nuclei, uniform ch...

Embodiment 3

[0032] Example 3: Effect of theabrownin (TB) on DNA damage in A375 cells

[0033] Comet assay was used to detect the effect of TB on the DNA strand damage of A375 cells. A375 was seeded in 6-well plates and treated with low, medium and high concentrations of TB. Cells were collected by centrifugation into pre-cooled PBS, and the cell concentration was adjusted to 1×10 5 pieces / ml. Prepare 1% normal melting point agarose gel on a frosted glass slide in advance, then preheat and mix 25 μl of cell suspension and 75 μl of 0.75% low melting point single agarose at 37°C, and quickly spread it on the first layer of gel superior. Place it in a 4°C environment and let it cure for more than 30 minutes. Then, in the pre-cooled alkaline electrophoresis buffer at 4°C, stand in the dark for 30 minutes. Next, lyse overnight in 4°C pre-cooled lysate. The electrophoresis condition is 1.0V / cm, and the time is 30min. After electrophoresis, take out the glass slide and place it in a glass ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The application of theabrownin in the preparation of anti-melanoma drugs belongs to the technical field of theabrownin application. The application includes: the effect of theabrownin in the preparation of drugs for inducing A375 human melanoma cell apoptosis; the application of theabrownin in the preparation of drugs for inhibiting melanoma as a natural substance; the use of theabrownin in the preparation of DNA damage agents as a natural substance Applications. The invention proves that theabrownin has an anti-proliferation effect on A375 cells, that theabrownin has a pro-apoptotic effect on A375 cells, that theabrownin causes DNA damage in A375 cells, that theabrownin affects the protein expression of A375 cells, and that theabrownin affects In vivo effects of A375 xenografts in zebrafish. The invention studies the apoptosis-promoting effect and mechanism of theabrownin on A375 human melanoma cells, and can be used to develop anti-melanoma drugs.

Description

technical field [0001] The invention belongs to the application technical field of theabrownin, and relates to the application of theabrownin in the preparation of anti-melanoma drugs, in particular to the effect of theabrownin in inducing apoptosis of A375 human melanoma cells. Background technique [0002] Melanoma is derived from epidermal melanocytes and can occur in any tissue containing these cells. It is a type of tumor with high degree of deterioration, insidious onset, and strong invasiveness. Its clinical features vary greatly, and most of the current clinical features of melanoma are mainly manifested in the following points: asymmetry; irregular, jagged, pitted or blurred edges; uneven color, showing various degrees of tan , brown or black; diameter greater than 6mm; with the evolution of the disease will increase or expand. Although the most common form of melanoma is cutaneous, it can also arise in any non-cutaneous site, including ocular, gastrointestinal, ge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/82A61P35/00A61K127/00
CPCA61K36/82A61P35/00
Inventor 张进
Owner 杭州茗褐生物科技有限公司